FDA Approved: CINACALCET — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental ANDA for Cinacalcet from Aurobindo Pharma Limited, expanding access to a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia Due to Parathyroid Carcinoma
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

SUPPL AP for CINACALCET (CINACALCET)